Negative Regulation of miR-375 by Interleukin-10 Enhances Bone Marrow-Derived Progenitor Cell-Mediated Myocardial Repair and Function After Myocardial Infarction
Open Access
- 25 August 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 33 (12), 3519-3529
- https://doi.org/10.1002/stem.2121
Abstract
Poor survival and function of transplanted cells in ischemic and inflamed myocardium likely compromises the functional benefit of stem cell-based therapies. We have earlier reported that co-administration of interleukin (IL)−10 and BMPAC enhances cell survival and improves left ventricular (LV) functions after acute myocardial infarction (MI) in mice. We hypothesized that IL-10 regulates microRNA-375 (miR-375) signaling in BMPACs to enhance their survival and function in ischemic myocardium after MI and attenuates left ventricular dysfunction after MI. miR-375 expression is significantly upregulated in BMPACs upon exposure to inflammatory/hypoxic stimulus and also after MI. IL-10 knockout mice display significantly elevated miR-375 levels. We report that ex vivo miR-375 knockdown in BMPAC before transplantation in the ischemic myocardium after MI significantly improve the survival and retention of transplanted BMPACs and also BMPAC-mediated post-infarct repair, neovascularization, and LV functions. Our in vitro studies revealed that knockdown of miR-375-enhanced BMPAC proliferation and tube formation and inhibited apoptosis; over expression of miR-375 in BMPAC had opposite effects. Mechanistically, miR-375 negatively regulated 3-phosphoinositide-dependent protein kinase-1 (PDK-1) expression and PDK-1-mediated activation of PI3kinase/AKT signaling. Interestingly, BMPAC isolated from IL-10-deficient mice showed elevated basal levels of miR-375 and exhibited functional deficiencies, which were partly rescued by miR-375 knockdown, enhancing BMPAC function in vitro and in vivo. Taken together, our studies suggest that miR-375 is negatively associated with BMPAC function and survival and IL-10-mediated repression of miR-375 enhances BMPAC survival and function. Stem Cells 2015;33:3519–3529Keywords
Funding Information
- NIH (HL091983, HL105597, HL126186, HL053354, HL108795, HL108806)
- American Heart Association Postdoctoral (15POST22720022)
- Scientist Development (14DG20480104)
This publication has 30 references indexed in Scilit:
- Myocardial knockdown of mRNA‐stabilizing protein HuR attenuates post‐MI inflammatory response and left ventricular dysfunction in IL‐10‐null miceThe FASEB Journal, 2010
- Function of microRNA‐375 and microRNA‐124a in pancreas and brainThe FEBS Journal, 2009
- PDK1 coordinates survival pathways and β-adrenergic response in the heartProceedings of the National Academy of Sciences of the United States of America, 2009
- Characterization of Pancreatic Transcription Factor Pdx-1 Binding Sites Using Promoter Microarray and Serial Analysis of Chromatin OccupancyPublished by Elsevier BV ,2007
- Intramyocardial Transplantation of Autologous CD34 + Stem Cells for Intractable AnginaCirculation, 2007
- Potential role of endothelial progenitor cells in the pathophysiology of heart failure: Clinical implications and perspectivesAtherosclerosis, 2006
- 3'phosphoinositide‐dependent kinase‐1 is essential for ischemic preconditioning of the myocardiumThe FASEB Journal, 2006
- Influence of Cardiovascular Risk Factors on Endothelial Progenitor CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Depletion of Endothelial Progenitor Cells in the Peripheral Blood of Patients With Rheumatoid ArthritisCirculation, 2005
- Integrin-Linked Kinase Regulates Endothelial Cell Survival and Vascular DevelopmentMolecular and Cellular Biology, 2004